Antimicrobial Peptide Therapeutics for Cystic Fibrosis

Greater than 90% of lung infections in cystic fibrosis (CF) patients are caused by Pseudomonas aeruginosa, and the majority of these patients subsequently die from lung damage. Current therapies are either targeted at reducing obstruction, reducing inflammation, or reducing infection. To identify po...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Zhang, Lijuan, Parente, Jody, Harris, Scott M., Woods, Donald E., Hancock, Robert E. W., Falla, Timothy J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2005
Onderwerpen:
Experimental Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1168697/
https://ncbi.nlm.nih.gov/pubmed/15980369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.7.2921-2927.2005
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items